The reality is more nuancedand depends largely on patient selection, dosing, and monitoring
Specifically, we aimed to examine the reasons for GLP-1 RA discontinuation across different time periods and to investigate whether these reasons differ depending on the medications intended usewhether prescribed for weight loss or for diabetes management
The lack of FDA pre-market approval means potential risks may not be identified until after widespread consumer use
Im happier, and I have more confidence
Hong understands why Medicaid programs, as well as private providers, want to cut back on covering the drugs, which can cost thousands of dollars per patient per year
63 Considering that T2DM and MASLD can reciprocally cause and affect each other, and given liraglutides potential therapeutic characteristics for MASLD, which may be beneficial for anti-fibrosis, more aggressive use of higher doses may bring greater clinical benefits in some groups, such as those with higher-grade fibrosis with or without T2DM